The Copper Ridge Institute (CRI) is evolving to become the Integrace Institute at Copper Ridge.
Integrace Institute at Copper Ridge is deeply committed to continuing research and education to support the care and treatment of individuals living with dementia. New initiatives, derived from an expanded emphasis on person-centered living and care practices, are also in development.
The goal of the Integrace Institute at Copper Ridge is to improve the quality of life for those with dementia, their loved ones, and the dedicated professionals who continue to devote their lives to this important work.
Please feel free to contact us with any questions or concerns.
Allison.email@example.com, Director of Dementia Education, (410) 795-8808 x 1116
October 14-15, 2016
Integrace Copper Ridge, 710 Obrecht Road, Sykesville, MD 21784
Presented by: Nicole Absar, MD, E-RYT 200; Cathy Reese, MSN, RN, RYT-500
Join us for a two day, interactive seminar to learn practical strategies for incorporating yoga and mindfulness into your work. Lead by Dr. Nicole Absar, a board certified neuropsychiatrist and registered yoga teacher, and Cathy Reese, an experienced nurse and yoga teacher, this unique program combines an in depth look at common brain disorders and how to tailor yoga approaches to
engage and support older adults and persons with neurodegenerative disorders.
November 7, 2016
Integrace Home Office, 576 Johsville Road, Sykesville, 21784
Presented by : Fatima Naqvi, MD, CMD; and Rev. Ann Boyd, PhD
Discount for early registration available until October 21, 2016
What are the factors that influence how we live, and die? How do our own experiences with death shape our personal views and beliefs? This highly interactive program will guide healthcare professionals through the process of examining their own views and beliefs on life and death. Participants will walk away with a deeper understanding of their own beliefs and values, and understand how these factors impact the way they support patients and families.
1. Dementia: Is it different in veterans?
2. Activity Programming for Individuals With Frontotemporal Dementia
3. Alzheimer’s Disease Research Update
4. Personalized Medicine: Its Role in Dementia and Long Term Care
5. Meeting the Needs of the Family
6. Improving Behavioral Health and Reducing the Innapropriate Use of Antipsychotics: Making it Happen
7. Music-based Therapy for Neurodegenerative Disorders
8. Dementia, Delirium, and Depression: How to recognize each when they coexist
ERK AD-Index as a Diagnostic Test for Alzheimer’s disease
A prospective study, conducted in collaboration with the Blanchette Rockefeller Neuroscience Institute, to develop a definitive diagnostic test for Alzheimer’s disease using cultured skin cells.
Function- and Behavior-Focused Care for Nursing Home Residents with Dementia
A clinical study testing a socioecological model and methods of modifying nursing staff activities to motivate and engage residents in behaviors that increase function and physical activity while minimizing resistance to care and other behavioral symptoms.
Implementation and Evaluation of a Pain Assessment Tool in a Dementia Care Facility
Evaluation of a pain assessment tool of quality improvement; specifically, pain monitoring and management, accreditation compliance, and decreasing need for psychotropic medications.
The Lived Experience and Meaning of the ‘Source’ of Caring in the Lives of Caregivers
An interpretive, phenomenological study designed to assess the psychosocial changes experienced by female caregivers and to reveal the nature of the source and experience of their caring.
The Effects of Personally Meaningful Music on Mood and Behavior in Persons with Alzheimer’s disease: An Exploratory Pilot Study
An exploratory study to determine if personally-meaningful music is more effective in improving mood and behavior than similar music without personal meaning among individuals with advanced dementia due to Alzheimer’s disease.
Pharmacogenomics in Elderly Patients: A Randomized-Controlled Trial (RCT) to Evaluate the Clinical Utility of GeneSight Psychotropic in Long-Term Care Patients with Dementia
GeneSight® is a Medicare-reimbursable procedure that uses a combinatorial psychiatric pharmacogenomics (CPGx) multi-gene approach to produce a personalized interpretive report that categorizes psychotropic medications into one of three groups based on objective, evidence-based, gene-drug interactions. This study will evaluate the clinical utility of GeneSight® for guiding psychotropic medication prescribing behavior of long-term care physicians, and on patient outcomes.
Phase III Trial of NUEDEXTA® for the Treatment of Agitation in Patients with Alzheimer’s disease
A clinical study to further assess the benefits and safety of NUEDEXTA® for treating agitation in Alzheimer’s disease. NUEDEXTA® (dextromethorphan hydrobromide and quinidine sulfate) is an oral investigational drug which has shown some possible benefits in treating behavioral symptoms in previous studies with other medical conditions.
To learn more about our current and prospective research initiatives, please contact Shannon O’Connor, MA, PhD(c), MS(c), Research Coordinator by email at Shannon.firstname.lastname@example.org or phone at (410) 795-8808 x 1150.